» Articles » PMID: 38796668

Annexin-A5 Monomer As a Membrane Repair Agent for the Treatment of Renal Ischemia-reperfusion Injury

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2024 May 25
PMID 38796668
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Renal ischemia-reperfusion injury (IRI) is one of the causes of acute kidney injury. Annexin A5 (AnxA5), a calcium-dependent cell membrane-binding protein, shows protective effects in various organ IRI models. This study explored the therapeutic effect of exogenous AnxA5 monomer protein on renal IRI and its potential mechanism of action.

Methods And Results: Different doses of AnxA5 were injected intravenously to treat bilateral renal IRI in SD rats. This model confirmed the protective effects of AnxA5 on kidney structure and function. In vitro, HK-2 cells were subjected to hypoxia for 12 h, followed by restoration of normal oxygen supply to simulate IRI. In vitro experiments demonstrated the mechanism of action of AnxA5 by measuring cellular activity and permeability. A comparison of the mutant AnxA5 protein M23 and the application of a calcium-free culture medium further validated the protective effect of AnxA5 by forming a network structure.

Conclusions: Exogenous AnxA5 monomers prevented renal IRI by binding to the damaged renal tubular epithelial cell membrane, forming a two-dimensional network structure to maintain cell membrane integrity, and ultimately prevent cell death.

Citing Articles

New Therapeutic Strategies in Retinal Vascular Diseases: A Lipid Target, Phosphatidylserine, and Annexin A5-A Future Theranostic Pairing in Ophthalmology.

Frostegard A, Haegerstrand A Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204083 PMC: 11357257. DOI: 10.3390/ph17080979.

References
1.
Wu M, Yiang G, Liao W, Tsai A, Cheng Y, Cheng P . Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cell Physiol Biochem. 2018; 46(4):1650-1667. DOI: 10.1159/000489241. View

2.
Eltzschig H, Eckle T . Ischemia and reperfusion--from mechanism to translation. Nat Med. 2011; 17(11):1391-401. PMC: 3886192. DOI: 10.1038/nm.2507. View

3.
Gameiro J, Carreiro C, Agapito Fonseca J, Pereira M, Jorge S, Gouveia J . Acute kidney disease and long-term outcomes in critically ill acute kidney injury patients with sepsis: a cohort analysis. Clin Kidney J. 2021; 14(5):1379-1387. PMC: 8087131. DOI: 10.1093/ckj/sfaa130. View

4.
Hu H, Zou C . Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic Perspectives. Curr Stem Cell Res Ther. 2016; 12(3):183-187. DOI: 10.2174/1574888X11666161024143640. View

5.
Sancho-Martinez S, Lopez-Novoa J, Lopez-Hernandez F . Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury. Clin Kidney J. 2015; 8(5):548-59. PMC: 4581387. DOI: 10.1093/ckj/sfv069. View